This is our regular report on hedge funds and alternative asset managers who are successfully protecting assets and outperforming the markets during the first months of 2020.

Biomedical companies continue to outperform

Vista Point Capital's flagship biotech fund - Parallax Biomedical Fund was up 2% (est.) in June and is up 11.7% year to date throug